2-methyl AP-237 & AP-238, Serum/Plasma

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80362

New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes


1	2-methyl AP-237	2-Me AP-237; 2-methyl Bucinnazine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	5.0	NPS, Synthetic Opioid
2	AP-238	2,6-dimethyl propionyl AP-237	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	5.0	NPS, Synthetic Opioid

Compliance Statement

This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.

Sample Type

Serum or Plasma

Requested Volume

1 mL

Minimum Volume

0.4 mL

Special Handling

Serum: Collect sample in Red top tube

Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.

Sample Container

Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical sample submissions only.

Stability

Room Temperature: 14 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): 14 day(s)

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.